Monomethyl fumarate Completed Phase 1 Trials for Multiple Sclerosis Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT04022473
Study to Compare GI Tolerability Following Oral Administration of Bafiertamâ„¢ or Tecfidera to Healthy Volunteers